| scholarly article | Q13442814 |
| P2093 | author name string | Dongmei Ye | |
| Rana Al-Sadi | |||
| Thomas Y Ma | |||
| Hamid M Said | |||
| P2860 | cites work | Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase | Q24294812 |
| The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
| Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability | Q24317362 | ||
| Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression | Q24536188 | ||
| Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease | Q70489716 | ||
| Is small intestinal permeability really increased in relatives of patients with Crohn's disease? | Q70734227 | ||
| Intestinal permeability and the prediction of relapse in Crohn's disease | Q72220492 | ||
| The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense | Q73049177 | ||
| Roles of platelet-activating factor, interleukin-1beta and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion | Q73097681 | ||
| Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora | Q73221864 | ||
| Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases | Q73503148 | ||
| The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling | Q28139111 | ||
| The interleukin-1 family: 10 years of discovery | Q28243296 | ||
| Intestinal mucosal barrier function in health and disease | Q29618086 | ||
| Biologic basis for interleukin-1 in disease | Q29619853 | ||
| Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease | Q30469576 | ||
| Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo | Q34014510 | ||
| Intestinal permeation and gastrointestinal disease | Q34119853 | ||
| Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis | Q34260899 | ||
| Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease | Q34392301 | ||
| Cytokine production in patients with inflammatory bowel disease | Q34395744 | ||
| Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers | Q34567309 | ||
| Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo | Q35052412 | ||
| Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper | Q35359745 | ||
| Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats. | Q35596401 | ||
| Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that the cytoskeleton may influence paracellular permeability and junctional charge selectivity | Q36215124 | ||
| MAP kinase kinase kinases and innate immunity | Q36342970 | ||
| Control of canonical NF-kappaB activation through the NIK-IKK complex pathway | Q36491362 | ||
| IL-1beta causes an increase in intestinal epithelial tight junction permeability | Q37047096 | ||
| Mechanism of cytokine modulation of epithelial tight junction barrier | Q37047106 | ||
| MAPKs and their relevance to arthritis and inflammation | Q37054686 | ||
| Cytokine regulation of tight junctions | Q37308566 | ||
| Crohn's disease--a permeability disorder of the tight junction? | Q39558113 | ||
| Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells | Q40116847 | ||
| Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process | Q40415725 | ||
| Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinase | Q40822768 | ||
| Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells | Q40929368 | ||
| Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. | Q41061126 | ||
| Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse | Q41122462 | ||
| IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. | Q41674827 | ||
| Stress-induced disruption of colonic epithelial barrier: role of interferon-gamma and myosin light chain kinase in mice | Q42797638 | ||
| Intestinal Na+-K+-ATPase activity and molecular events downstream of interferon-gamma receptor stimulation | Q43262266 | ||
| Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract | Q43624355 | ||
| Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis | Q44121388 | ||
| The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeability, mucosal TNFalpha production and nuclear factor kappa B expression | Q44535156 | ||
| TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation | Q44758263 | ||
| Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression | Q45258065 | ||
| Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase | Q46044996 | ||
| Two pathways to NF-kappaB. | Q46113107 | ||
| Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier | Q46941133 | ||
| IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways | Q48457874 | ||
| IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India. | Q54648083 | ||
| Clostridium difficile toxin B disrupts the barrier function of T84 monolayers | Q67732507 | ||
| Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor | Q69656337 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| P304 | page(s) | 2310-2322 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | IL-1beta-induced increase in intestinal epithelial tight junction permeability is mediated by MEKK-1 activation of canonical NF-kappaB pathway | |
| P478 | volume | 177 |
| Q37623049 | Allergic diseases in the elderly: biological characteristics and main immunological and non-immunological mechanisms |
| Q36254148 | Alpha-Melanocyte Stimulating Hormone Protects against Cytokine-Induced Barrier Damage in Caco-2 Intestinal Epithelial Monolayers |
| Q38750089 | Anti-inflammatory effects of Bifidobacterium longum subsp infantis secretions on fetal human enterocytes are mediated by TLR-4 receptors |
| Q89546520 | Calycosin alleviates allergic contact dermatitis by repairing epithelial tight junctions via down-regulating HIF-1α |
| Q38909421 | Cholinergic receptor activation on epithelia protects against cytokine-induced barrier dysfunction |
| Q37095261 | Conditional knockout of polarity complex (atypical) PKCι reveals an anti-inflammatory function mediated by NF-κB. |
| Q28578305 | Cryptorchidism-induced CFTR down-regulation results in disruption of testicular tight junctions through up-regulation of NF-κB/COX-2/PGE2 |
| Q27324323 | Early mucosal sensing of SIV infection by paneth cells induces IL-1β production and initiates gut epithelial disruption |
| Q90402708 | Effect of arabinoxylan on colonic bacterial metabolites and mucosal barrier in high-fat diet-induced rats |
| Q37578273 | Effects of oral glutamine supplementation on exercise-induced gastrointestinal permeability and tight junction protein expression |
| Q38100639 | Emerging evidence on the pathobiology of mucositis |
| Q38120647 | Emerging evidence on the pathobiology of mucositis. |
| Q38058390 | Exercise regulation of intestinal tight junction proteins |
| Q37051554 | Gastroesophageal reflux activates the NF-κB pathway and impairs esophageal barrier function in mice |
| Q59328937 | Impaired COMMD10-Mediated Regulation of Ly6C Monocyte-Driven Inflammation Disrupts Gut Barrier Function |
| Q64880411 | Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis |
| Q28730963 | Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice |
| Q38902578 | Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair |
| Q95266780 | Integrative Analysis of the Genes Induced by the Intestine Microbiota of Infant Born to Term and Breastfed |
| Q38698442 | Interleukin-1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. |
| Q37249263 | Interleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions |
| Q64246397 | Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis |
| Q92356819 | Intestinal barrier dysfunction in severe burn injury |
| Q35534039 | Intestinal dendritic cells change in number in fulminant hepatic failure |
| Q34720051 | Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status |
| Q26859272 | Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases |
| Q41741480 | Involvement of intracellular signaling in the IL-1β inhibitory effect on fructose intestinal absorption |
| Q61796773 | Long-term in vitro 3D hydrogel co-culture model of inflammatory bowel disease |
| Q33729648 | Maternal obesity induces gut inflammation and impairs gut epithelial barrier function in nonobese diabetic mice |
| Q92184716 | Measurement of novel intestinal secretory and barrier pathways and effects of proteases |
| Q36914746 | Mechanism of IL-1β modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation |
| Q92051810 | Mechanisms Underlying Bone Loss Associated with Gut Inflammation |
| Q39126706 | Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells. |
| Q37661367 | Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). |
| Q90636691 | Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis |
| Q41378914 | Pseudomonas fluorescens alters the intestinal barrier function by modulating IL-1β expression through hematopoietic NOD2 signaling. |
| Q34287155 | Regulation of intestinal epithelial permeability by tight junctions. |
| Q38141920 | Regulation of paracellular permeability: factors and mechanisms. |
| Q49950008 | Regulatory effects of saponins from Panax japonicus on colonic epithelial tight junctions in aging rats |
| Q36291721 | Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction. |
| Q34463139 | Republished: tracing PAKs from GI inflammation to cancer |
| Q35625519 | Salvianolic Acid B Ameliorates Lipopolysaccharide-Induced Albumin Leakage from Rat Mesenteric Venules through Src-Regulated Transcelluar Pathway and Paracellular Pathway |
| Q35111744 | Specialized metabolites from the microbiome in health and disease |
| Q41582124 | Systematic Analysis of Quantitative Logic Model Ensembles Predicts Drug Combination Effects on Cell Signaling Networks |
| Q36885702 | TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway. |
| Q28730877 | Tetrahydro iso-alpha acids from hops improve glucose homeostasis and reduce body weight gain and metabolic endotoxemia in high-fat diet-fed mice |
| Q46235419 | The JAK2 variant rs10758669 in Crohn's disease: altering the intestinal barrier as one mechanism of action |
| Q37899787 | The biology of interleukin-1: emerging concepts in the regulation of the actin cytoskeleton and cell junction dynamics |
| Q97093738 | The past, present and future of intestinal in vitro cell systems for drug absorption studies |
| Q61811129 | Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk |
| Q38210506 | Tracing PAKs from GI inflammation to cancer. |
| Q36285773 | Tumor necrosis factor alpha increases intestinal permeability in mice with fulminant hepatic failure |
| Q50920142 | Tumour necrosis factor--induced loss of intestinal barrier function requires TNFR1 and TNFR2 signalling in a mouse model of total parenteral nutrition. |
| Q54588131 | VSL#3 probiotics provide protection against acute intestinal ischaemia/reperfusion injury. |
Search more.